PLoS ONE (Jan 2019)

Health-related quality of life in patients with atrial fibrillation: The role of symptoms, comorbidities, and the type of atrial fibrillation.

  • Fabienne Witassek,
  • Anne Springer,
  • Luise Adam,
  • Stefanie Aeschbacher,
  • Jürg H Beer,
  • Steffen Blum,
  • Leo H Bonati,
  • David Conen,
  • Richard Kobza,
  • Michael Kühne,
  • Giorgio Moschovitis,
  • Stefan Osswald,
  • Nicolas Rodondi,
  • Christian Sticherling,
  • Thomas Szucs,
  • Matthias Schwenkglenks,
  • Swiss-AF study investigators

DOI
https://doi.org/10.1371/journal.pone.0226730
Journal volume & issue
Vol. 14, no. 12
p. e0226730

Abstract

Read online

AimsThis study aimed to analyse health related quality of life (HRQoL) for patients with different atrial fibrillation (AF) types and to identify patient characteristics, symptoms and comorbidities that influence HRQoL.MethodsWe used baseline data from the Swiss Atrial Fibrillation (Swiss-AF) study, a prospective multicentre observational cohort study conducted in 13 clinical centres in Switzerland. Between April 2014 and August 2017, 2415 AF patients were recruited. Patients were included in this analysis if they had baseline HRQoL data as assessed with EQ-5D-based utilities and visual analogue scale (VAS) scores. Patient characteristics and HRQoL were described stratified by AF type. The impact of symptoms, comorbidities and socio-economic factors on HRQoL was analysed using multivariable regression analysis.ResultsBased on 2412 patients with available baseline HRQoL data, the lowest unadjusted mean HRQoL was found in patients with permanent AF regardless of whether measured with utilities (paroxysmal: 0.83, persistent: 0.84, permanent: 0.80, pConclusionsMultiple factors turned out to influence HRQoL in AF patients. After controlling for several comorbidities, the EHRA score was one of the strongest predictors independent of AF type. The results may be valuable for better patient assessment and provide a reference point for further QoL and health economic analyses in AF populations.